1. Baylor College of Medicine
  2. Healthcare
  3. Clinical Trials
  4. Results

Search for Clinical Trials

S2207: Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment (H-54903)
S2207: Randomized Phase II Study of the Addition of Targeted Therapeutic Agents to Tafasitamab-Based Therapy in Non-Transplant-Eligible Patients With…
  • Cancer - All
  • Cancer - Hematology
  • Cancer - Lymphoma
  • Hematology
View Clinical Trial
GLOFIT: Evaluating Glofitamab + Gemcitabine + Oxaliplatin in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (H-55651)
GLOFIT: A Phase Ib Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Glofitamab in Combination With Gemcitabine Plus…
  • Cancer - All
  • Cancer - Hematology
  • Cancer - Lymphoma
  • Hematology
View Clinical Trial
SKYGLO (GO44145): Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma (H-55787)
A Phase III, Multicenter, Randomized, Open-Label Study Comparing the Efficacy and Safety of Glofitamab (RO7082859) in Combination With Polatuzumab…
  • Cancer - All
  • Cancer - Hematology
  • Cancer - Lymphoma
  • Hematology
View Clinical Trial
Back to topback-to-top